Post-earnings recap
Reported
Thu, May 7, 2026
EPS actual
$1.97
EPS est.
$1.33
EPS surprise
+48.12%
1-day move
+2.91%
ICU Medical reported better-than-expected earnings per share, which contributed to a positive stock reaction, rising by 2.91%. However, revenue figures were not disclosed, leaving some uncertainty about overall performance. The strong EPS surprise indicates potential operational strength, but the lack of revenue data means investors should remain cautious.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.97 | $1.75 | +48.12% |
| Revenue | N/A | $531M | N/A |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.
ICU Medical, Inc. is a healthcare company focused on developing and manufacturing innovative medical devices, particularly in the area of infusion therapy. With a market cap of $3 billion, it plays a crucial role in providing essential healthcare supplies that improve patient care and safety.
Last quarter
In Q4 2025, ICU Medical reported an EPS of $1.91, significantly exceeding expectations. However, the stock experienced a slight decline of 1.25% the following day.
Management promises and guidance
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+74.78%
Avg 1-day reaction
+1.12%
Analysts expect ICU Medical to report strong earnings, continuing its trend of beating estimates. The consensus EPS is set at $1.75, reflecting optimism about the company's growth.
Bull case
If ICU Medical exceeds the EPS estimate, it could reinforce investor confidence and lead to a positive stock reaction, especially given its history of surprises.
Bear case
Conversely, if the company fails to meet expectations, it may raise concerns about its growth trajectory and impact the stock negatively.
Key metrics to watch
EPS
$1.75Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.
Revenue
$531MRevenue growth is vital for assessing the company's ability to expand and capture market share in the healthcare sector.
The print will turn on these.
Q1
Will EPS exceed the consensus estimate of $1.75?
A beat on EPS would continue the trend of strong performance and could lead to a positive market reaction.
Q2
What guidance will management provide regarding revenue growth?
Investors will closely watch for any indications of future growth, especially in light of recent strong earnings.
—
Est. EPS
$0.97
Est. Rev
$754M
Impl. Move
±9.1%
Why consensus could be wrong
The consensus may underestimate ICU Medical's ability to maintain its growth trajectory, especially given its recent strong performance.
Supporting evidence
The company has consistently beaten EPS estimates, indicating strong operational execution.
Options pricing suggests a larger move than historical averages, hinting at potential surprises.
Recent performance trends in the healthcare sector may not fully reflect ICU Medical's unique position and growth potential.
Key risk
If revenue growth falls short of $516M, it could challenge the optimistic outlook and lead to a reevaluation of the stock.
Pre-commit to what would confirm each case.
This quarter's performance will be closely scrutinized as it follows a series of strong earnings surprises, setting high expectations.
Bull confirmed if
An EPS of $1.80 or higher would confirm the bullish outlook and suggest strong operational performance.
Bear confirmed if
An EPS below $1.66 could signal potential issues in meeting growth expectations.
What the market is pricing for the move.
Implied Move
±9.91%
Historical Avg
±2.2%
The options market is pricing in a significant move, suggesting that investors are anticipating volatility around the earnings report.
Options are pricing ±8.9% while ICUI has averaged ±2.2% over the last 8 prints — setup is pricing rich.
ATM IV
0.7%
30d HV
34.7%
Smart-money positioning from the most recent 13F filings.
Institutional
115.79%
of float
Insider
1.75%
of float
Holders
397
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
3,753,409 sh · $585.6M
15.02%
4.0%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If ICU Medical beats expectations, history suggests the stock could rise by about 0.7%, confirming ongoing growth momentum.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors digest the news.
Miss
A miss on earnings could lead to a decline, with historical data suggesting a potential drop similar to past reactions.
The lines on the call that would change the story.
Jupiter Topco LLC
2,781,620 sh · $434.0M
11.13%
100.0%
Vanguard Portfolio Management LLC
1,470,583 sh · $229.5M
5.88%
2.3%
Fuller & Thaler Asset Management Inc.
1,298,127 sh · $202.5M
5.19%
6.4%
Vanguard Capital Management LLC
1,123,237 sh · $175.3M
4.49%
1.0%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.